Risk factors for the development of interstitial lung disease following severe COVID-19 pneumonia and outcomes of systemic corticosteroid therapy: 3-month follow-up.

Autor: Günay S; Department of Pulmonary Diseases, Ankara Bilkent City Hospital, Ankara, Turkiye . sibelgunay@gmail.com., Parlak IS; Department of Radiology, Ankara Bilkent City Hospital, Ankara, Turkiye . selcukparlakdr@gmail.com., Hezer H; Department of Pulmonary Diseases, Ankara Bilkent City Hospital, Ankara, Turkiye . hoflaz@yahoo.com., Şeref Parlak EŞ; ebrusengulparlak@gmail.com., Umut MS; Department of Pulmonary Diseases, Ankara Bilkent City Hospital, Ankara, Turkiye . melikeerdas@gmail.com., Hancıoğlu Z; Department of Pulmonary Diseases, Ankara Bilkent City Hospital, Ankara, Turkiye . dr.zeynepcinar@hotmail.com., Çelenk Ergüden H; Department of Pulmonary Diseases, Ankara Bilkent City Hospital, Ankara, Turkiye . hcelenk78@gmail.com., Kocaman Y; Department of Pulmonary Diseases, Ankara Bilkent City Hospital, Ankara, Turkiye . ykocaman1@hotmail.com., Dalkıran A; dr.aynill@gmail.com., Sertçelik Ü; umranozdensertcelik@yahoo.com., Şerifoğlu İ; iremish@yahoo.com.tr., Akpınar E; gurel_esma@yahoo.com., Göktaş MF; mfrkngkts@gmail.com., Fidan M; meltemfidann@windowslive.com., Babahanoğlu B; bsra.babahanoglu@gmail.com., Cander FS; fscander95@gmail.com., Çıvgın E; esracivgin@gmail.com., Er M; mukreminer@hotmail.com., Kılıç H; drhaticeb@yahoo.com., Argüder E; drgullu2000@gmail.com., Tuğ T; tugtuncer@hotmail.com., Ünsal E; unsalebru73@yahoo.com., Hasanoğlu C; hhasanoglu@hotmail.com., Günay İ; irempkz@gmail.com., Babayiğit M; muhammetbabayiğit93@gmail.com., Ağca B; busraagca01@hotmail.com., Karalezli A; aysegulkaralezli@gmail.com.

Publikováno v: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG [Sarcoidosis Vasc Diffuse Lung Dis] 2023 Sep 13; Vol. 40 (3), pp. e2023029. Date of Electronic Publication: 2023 Sep 13.